By Rachel Cohrs Zhang, Derek Wallbank, and Hadriana Lowenkron President Donald Trump said he plans to order a cut in US ...

Hypnotherapy, for instance, induces a focused, altered state of consciousness that allows patients to reprocess the sensory and emotional components ... for Aptinyx, Daiichi Sankyo, Intec ...

Digital technology should not be restricted to using digital channels for scientific communication; digital components should ... AstraZeneca and Daiichi Sankyo's Enhertu has been shown to provide ...

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSNKY) announced Wednesday that Enhertu, their jointly developed antibody-drug conjugate, reached the main goal in a Phase 3 trial in certain ...

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive ...

Welcome to Zymeworks first-quarter 2025 results conference call and webcast. (Operator Instructions) I would now like to turn the conference over to Shrinal Inamdar, Senior Director of Investor ...

AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for their TROP2-directed antibody-drug conjugate (ADC) for breast cancer, Datroway, the latest to emerge from ...

Nippon Ichi Software Inc. (3851.TO) Japan Year Ended March 31 GROUP 2025 2024 Revenue Y5.30 bln Y5.34 bln Operating Profit (Y274.00 mln) Y401.00 mln Pretax Profit (Y75.00 mln) Y842.00 mln Net ...

But since that time, MS&AD has been a seller, offloading its 15.1 per cent interest at $8.46 per share or $884m to rival Dai-ichi, which many now suspect will eventually bid to buy Challenger.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

US President Donald Trump said Sunday he was ordering new tariffs on all films made outside the United States, claiming ...